{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:38:58Z","timestamp":1792629538428,"version":"4.5.0"},"reference-count":31,"publisher":"MyJove Corporation","issue":"155","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/60048","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T19:00:14Z","timestamp":1580497214000},"source":"Crossref","is-referenced-by-count":0,"title":["Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice"],"prefix":"10.3791","author":[{"given":"Ming","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengde","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongzhi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"issue":"1","key":"ref1","first-page":"0","type":"journal-article","article-title":"The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis","volume":"35","author":"Tob\u00f3n","year":"2010","unstructured":"Tob\u00f3n, G. J, Youinou, P, Saraux, A. The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritis. Autoimmunity Reviews. 35 (1), 0-14 (2010).","journal-title":"Autoimmunity Reviews"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","type":"journal-article","article-title":"The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study","volume":"73","author":"Cross","year":"2014","unstructured":"Cross, M. et al. The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases. 73 (7), 1316-1322 (2014).","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2217\/bem-2018-0001","type":"journal-article","article-title":"From neuroimunomodulation to bioelectronic treatment of rheumatoid arthritis","volume":"1","author":"Kanashiro","year":"2018","unstructured":"Kanashiro, A., Bassi, G. S., Queir\u00f3z Cunha, F. D., Ulloa, L. From neuroimunomodulation to bioelectronic treatment of rheumatoid arthritis. Bioelectronics in Medicine. 1 (2), 151-165 (2018).","journal-title":"Bioelectronics in Medicine"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri3369","type":"journal-article","article-title":"Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions","volume":"13","author":"Brennan","year":"2013","unstructured":"Brennan, P.J., Brigl, M., Brenner, M.B. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nature Reviews Immunology. 13 (2), 101-117 (2013).","journal-title":"Nature Reviews Immunology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3389\/fimmu.2017.01950","type":"journal-article","article-title":"Unraveling Natural Killer T-Cells Development","volume":"8","author":"Bianca","year":"2018","unstructured":"Bianca, B. S. Unraveling Natural Killer T-Cells Development. Frontiers in Immunology. 8, 1950 (2018).","journal-title":"Frontiers in Immunology"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/rheumatology\/kel119","type":"journal-article","article-title":"Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases","volume":"45","author":"Mitsuo","year":"2006","unstructured":"Mitsuo, A. et al. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases. Rheumatology. 45 (12), 1477-1484 (2006).","journal-title":"Rheumatology"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1002\/eji.200535235","type":"journal-article","article-title":"Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway","volume":"35","author":"Miellot","year":"2005","unstructured":"Miellot, A. et al. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway. European Journal of Immunology. 35 (12), 3704-3713 (2005).","journal-title":"European Journal of Immunology"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2567.2009.03235.x","type":"journal-article","article-title":"Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment","volume":"130","author":"Miellot-Gafsou","year":"2010","unstructured":"Miellot-Gafsou, A. et al. Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment. Immunology. 130 (2), 296-306 (2010).","journal-title":"Immunology"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/ard.2009.125849","type":"journal-article","article-title":"Profound invariant natural killer t-cell deficiency in inflammatory arthritis","volume":"69","author":"Tudhope","year":"2010","unstructured":"Tudhope, S. J., Delwig, A. V., Falconer, J., Pratt, A., Ng, W. F. Profound invariant natural killer t-cell deficiency in inflammatory arthritis. Annals of the Rheumatic Diseases. 69 (10), 1873-1879 (2010).","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"02","key":"ref10","first-page":"218","type":"journal-article","article-title":"Effects on immunoregulation of iNKT cells in RA by novel synthetic immunostimulator CH1b","volume":"32","author":"Ming","year":"2016","unstructured":"Ming, M. et al. Effects on immunoregulation of iNKT cells in RA by novel synthetic immunostimulator CH1b. Chinese Journal of Immunology. 32 (02), 218-222 (2016).","journal-title":"Chinese Journal of Immunology"},{"issue":"3","key":"ref11","first-page":"213","type":"journal-article","article-title":"Study of the correlation between the percentage of iNKT cells and the ratio of IFN-\u03b3\/IL-4 in patients with rheumatoid arthritis","volume":"35","author":"Ming","year":"2015","unstructured":"Ming, M. et al. Study of the correlation between the percentage of iNKT cells and the ratio of IFN-\u03b3\/IL-4 in patients with rheumatoid arthritis. Chinese Journal of Microbiology Immunology. 35 (3), 213-218 (2015).","journal-title":"Chinese Journal of Microbiology Immunology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nm0901-1057","type":"journal-article","article-title":"Activation of natural killer T cells by \u03b1-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes","volume":"7","author":"Sharif","year":"2010","unstructured":"Sharif, S. et al. Activation of natural killer T cells by \u03b1-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nature Medicine. 7, 1057-1062 (2010).","journal-title":"Nature Medicine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coi.2016.01.001","type":"journal-article","article-title":"Development of invariant natural killer T cells","volume":"39","author":"Gapin","year":"2016","unstructured":"Gapin, L. Development of invariant natural killer T cells. Current Opinion in Immunology. 39, 68-74 (2016).","journal-title":"Current Opinion in Immunology"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","DOI":"10.4110\/in.2017.17.6.365","type":"journal-article","article-title":"Lineage Differentiation Program of Invariant Natural Killer T Cells","volume":"17","author":"Kwon","year":"2017","unstructured":"Kwon, D. I., Lee, Y. J. Lineage Differentiation Program of Invariant Natural Killer T Cells. Immune Network. 17 (6) (2017).","journal-title":"Immune Network"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1038\/s41598-017-07365-8","type":"journal-article","article-title":"The differentiation of ROR-\u03b3t expressing iNKT17 cells is orchestrated by Runx1","volume":"7","author":"Thapa","year":"2017","unstructured":"Thapa, P. et al. The differentiation of ROR-\u03b3t expressing iNKT17 cells is orchestrated by Runx1. Scientific Reports. 7 (1), 7018 (2017).","journal-title":"Scientific Reports"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1089\/jir.2011.0056","type":"journal-article","article-title":"Collagen-induced arthritis as an animal model for rheumatoid arthritis: focuson interferon-\u03b3","volume":"31","author":"Schurgers","year":"2011","unstructured":"Schurgers, E., Billiau, A., Matthys, P. Collagen-induced arthritis as an animal model for rheumatoid arthritis: focuson interferon-\u03b3. Interferon Cytokine Research. 31 (12), 917-926 (2011).","journal-title":"Interferon Cytokine Research"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40273-014-0139-9","type":"journal-article","article-title":"How cost-effectiveness A systematic review and stepwise approach for selecting a transferable health economic evaluation rheumatoid arthritis","volume":"32","author":"Van Haalen","year":"2014","unstructured":"Van Haalen, H. G. M., Severens, J. L., Tran-Duy, A., Boonen, A. How to select the right cost-effectiveness model: A systematic review and stepwise approach for selecting a transferable health economic evaluation model for rheumatoid arthritis. Pharmacoeconomics. 32 (5), 429-442 (2014).","journal-title":"Pharmacoeconomics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.4049\/jimmunol.172.7.4503","type":"journal-article","article-title":"Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice","volume":"172","author":"Schubert","year":"2004","unstructured":"Schubert, D., Maier, B., Morawietz, L., Krenn, V., Kamradt, T. Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. Journal of Immunology. 172, 4503-4509 (2004).","journal-title":"Journal of Immunology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"131613","DOI":"10.1186\/ar1829","type":"journal-article","article-title":"Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase","volume":"7","author":"Bockermann","year":"2005","unstructured":"Bockermann, R., Schubert, D., Kamradt, T., Holmdahl, R. Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase. Arthritis Research, Therapy. 7, R131613-24 (2005).","journal-title":"Arthritis Research, Therapy"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/ar1476","type":"journal-article","article-title":"The role and clinical implications of G6PI in experimental models of rheumatoid arthritis","volume":"7","author":"Kamradt","year":"2005","unstructured":"Kamradt, T., Schubert, D. The role and clinical implications of G6PI in experimental models of rheumatoid arthritis. Arthritis Research, Therapy. 7, 20-28 (2005).","journal-title":"Arthritis Research, Therapy"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"51215","DOI":"10.1371\/journal.pone.0051215","type":"journal-article","article-title":"Activation of Invariant NKT Cells with Glycolipid Ligand \u03b1-Galactosylceramide Ameliorates Glucose-6-Phosphate Isomerase Peptide-Induced Arthritis","volume":"7","author":"Horikoshi","year":"2012","unstructured":"Horikoshi, M. et al. Activation of Invariant NKT Cells with Glycolipid Ligand \u03b1-Galactosylceramide Ameliorates Glucose-6-Phosphate Isomerase Peptide-Induced Arthritis. PlosOne. 7 (12), e51215 (2012).","journal-title":"PlosOne"},{"issue":"3","key":"ref22","first-page":"569","type":"journal-article","article-title":"Immunization with mixed peptides derived from glucose-6-phosphate isomerase induces rheumatoid arthritis in DBA \/1 mice","volume":"32","author":"Zhang","year":"2016","unstructured":"Zhang, X.J. et al. Immunization with mixed peptides derived from glucose-6-phosphate isomerase induces rheumatoid arthritis in DBA \/1 mice. Chinese Journal of Pathophysiology. 32 (3), 569-576 (2016).","journal-title":"Chinese Journal of Pathophysiology"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2217\/1750743X.1.1.73","type":"journal-article","article-title":"Invariant natural killer T cell-based immunotherapy for cancer","volume":"1","author":"Motohashi","year":"2017","unstructured":"Motohashi, S., Nakayama, T. Invariant natural killer T cell-based immunotherapy for cancer. Immunotherapy. 1 (1), 73 (2017).","journal-title":"Immunotherapy"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3858\/emm.2010.42.8.055","type":"journal-article","article-title":"The requirement of natural killer T-cells in tolerogenic APCs-mediated suppression of collagen-induced arthritis","volume":"42","author":"Jung","year":"2010","unstructured":"Jung, S. et al. The requirement of natural killer T-cells in tolerogenic APCs-mediated suppression of collagen-induced arthritis. Experimental and Molecular Medicine. 42 (8), 547-554 (2010).","journal-title":"Experimental and Molecular Medicine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3389\/fimmu.2018.00519","type":"journal-article","article-title":"Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity","volume":"9","author":"Luc","year":"2018","unstructured":"Luc, V. K., Lan, W. Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity. Frontiers in Immunology. 9, 519-526 (2018).","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/art.11489","type":"journal-article","article-title":"Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of \u03b1-galactosylceramide","volume":"50","author":"Chiba","year":"2004","unstructured":"Chiba, A. et al. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of \u03b1-galactosylceramide. Arthritis, Rheumatism. 50 (1), 305-313 (2004).","journal-title":"Arthritis, Rheumatism"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1136\/ard.2009.125849","type":"journal-article","article-title":"Profound invariant natural killer t-cell deficiency in inflammatory arthritis","volume":"69","author":"Tudhope","year":"2010","unstructured":"Tudhope, S. J., Delwig, A. V., Falconer, J., Pratt, A., Ng, W. F. Profound invariant natural killer t-cell deficiency in inflammatory arthritis. Annals of the Rheumatic Diseases. 69 (10), 1873-1879 (2010).","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","DOI":"10.1186\/ar2777","type":"journal-article","article-title":"Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA\/1 mice","volume":"11","author":"Bruns","year":"2009","unstructured":"Bruns, L. et al. Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA\/1 mice. Arthritis Research, Therapy. 11 (4) (2009).","journal-title":"Arthritis Research, Therapy"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clim.2009.11.007","type":"journal-article","article-title":"Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis","volume":"134","author":"Parietti","year":"2010","unstructured":"Parietti, V. et al. Rituximab treatment overcomes reduction of regulatory iNKT cells in patients with rheumatoid arthritis. Clinical Immunology. 134 (3), 331-339 (2010).","journal-title":"Clinical Immunology"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1248\/bpb.b14-00873","type":"journal-article","article-title":"Functional mechanism(s) of the inhibition of disease progression by combination treatment with fingolimod plus pathogenic antigen in a glucose-6-phosphate isomerase peptide-induced arthritis mouse model","volume":"38","author":"Yoshida","year":"2015","unstructured":"Yoshida, Y. et al. Functional mechanism(s) of the inhibition of disease progression by combination treatment with fingolimod plus pathogenic antigen in a glucose-6-phosphate isomerase peptide-induced arthritis mouse model. Biological, Pharmaceutical Bulletin. 38 (8), 1120-1125 (2015).","journal-title":"Biological, Pharmaceutical Bulletin"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.intimp.2018.12.040","type":"journal-article","article-title":"Study of the adoptive immunotherapy on rheumatoid arthritis with Thymus-derived invariant natural killer T cells","volume":"67","author":"Chen","year":"2019","unstructured":"Chen, D. et al. Study of the adoptive immunotherapy on rheumatoid arthritis with Thymus-derived invariant natural killer T cells. International Immunopharmacology. 67, 427-440 (2019).","journal-title":"International Immunopharmacology"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/60048\/adoptive-immunotherapy-inkt-cells-glucose-6-phosphate-isomerase-g6pi","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:40:29Z","timestamp":1792626029000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/60048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":31,"journal-issue":{"issue":"155","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3791\/60048","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]}}}